These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 3085902

  • 1. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M, Hock JM, Gera I, Fonseca J, Poser J, Bevan J, Raisz LG.
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [Abstract] [Full Text] [Related]

  • 2. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats.
    Gunness-Hey M, Gera I, Fonseca J, Raisz LG, Hock JM.
    Calcif Tissue Int; 1988 Nov; 43(5):284-8. PubMed ID: 3145794
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of undermineralized matrix formation by 1,25 dihydroxyvitamin D3 in long bones of rats.
    Hock JM, Gunness-Hey M, Poser J, Olson H, Bell NH, Raisz LG.
    Calcif Tissue Int; 1986 Feb; 38(2):79-86. PubMed ID: 3082498
    [Abstract] [Full Text] [Related]

  • 4. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gautvik KM, Gordeladze JO.
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [Abstract] [Full Text] [Related]

  • 5. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo.
    Hock JM, Hummert JR, Boyce R, Fonseca J, Raisz LG.
    J Bone Miner Res; 1989 Jun; 4(3):449-58. PubMed ID: 2527459
    [Abstract] [Full Text] [Related]

  • 6. 1,25-Dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats.
    Burnatowska-Hledin MA, Doyle TM, Eadie MJ, Mayor GH.
    J Lab Clin Med; 1986 Aug; 108(2):96-102. PubMed ID: 3755457
    [Abstract] [Full Text] [Related]

  • 7. Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats.
    Gunness-Hey M, Hock JM.
    Bone; 1989 Aug; 10(6):447-52. PubMed ID: 2624826
    [Abstract] [Full Text] [Related]

  • 8. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.
    Epstein S, Schlosberg M, Fallon M, Thomas S, Movsowitz C, Ismail F.
    Calcif Tissue Int; 1990 Sep; 47(3):152-7. PubMed ID: 2224590
    [Abstract] [Full Text] [Related]

  • 9. Indomethacin does not inhibit the anabolic effect of parathyroid hormone on the long bones of rats.
    Gera I, Hock JM, Gunness-Hey M, Fonseca J, Raisz LG.
    Calcif Tissue Int; 1987 Apr; 40(4):206-11. PubMed ID: 3107773
    [Abstract] [Full Text] [Related]

  • 10. Concurrent warfarin treatment further reduces bone mineral levels in 1,25-dihydroxyvitamin D3-treated rats.
    Price PA, Sloper SA.
    J Biol Chem; 1983 May 25; 258(10):6004-7. PubMed ID: 6602126
    [Abstract] [Full Text] [Related]

  • 11. The dichotomy in the effects of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on bone gamma-carboxyglutamic acid-containing protein in serum and bone in vitamin D-deficient rats.
    Wientroub S, Price PA, Reddi AH.
    Calcif Tissue Int; 1987 Mar 25; 40(3):166-72. PubMed ID: 3105848
    [Abstract] [Full Text] [Related]

  • 12. 1,25-Dihydroxyvitamin D3 modulates glucocorticoid-induced alteration in serum bone Gla protein and bone histomorphometry.
    Jowell PS, Epstein S, Fallon MD, Reinhardt TA, Ismail F.
    Endocrinology; 1987 Feb 25; 120(2):531-6. PubMed ID: 3492365
    [Abstract] [Full Text] [Related]

  • 13. Regulatory effect of calcium-regulating hormones on the synthesis and/or secretion of bone gamma-carboxyglutamic acid-containing protein in chick embryonic calvaria in vitro.
    Tsutsumi C, Hoshiba K, Moriuchi S, Orimo H, Hosoya N.
    J Nutr Sci Vitaminol (Tokyo); 1986 Apr 25; 32(2):157-69. PubMed ID: 3020205
    [Abstract] [Full Text] [Related]

  • 14. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.
    Finch JL, Brown AJ, Mori T, Nishii Y, Slatopolsky E.
    J Bone Miner Res; 1992 Jul 25; 7(7):835-9. PubMed ID: 1642151
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells.
    Klaus G, von Eichel B, May T, Hügel U, Mayer H, Ritz E, Mehls O.
    Endocrinology; 1994 Oct 25; 135(4):1307-15. PubMed ID: 7523093
    [Abstract] [Full Text] [Related]

  • 17. Effects of oxidation of human parathyroid hormone on its biological activity in continuously infused, thyroparathyroidectomized rats.
    Horiuchi N.
    J Bone Miner Res; 1988 Jun 25; 3(3):353-8. PubMed ID: 3213628
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of calcium-regulating hormones on bone metabolism in weanling rats orally administered zinc sulfate.
    Yamaguchi M, Inamoto K.
    Metabolism; 1986 Nov 25; 35(11):1044-7. PubMed ID: 3773722
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.